Middle East and Africa Robot Assisted Percutaneous Coronary Intervention (PCI) Market, By Product Type (Robotic Systems, Instruments, and Accessories), End User (Hospitals, Cath Labs, and Others) - Industry Trends and Forecast to 2030.
Middle East and Africa Robot Assisted Percutaneous Coronary Intervention (PCI) Market Analysis and Size
Percutaneous coronary intervention (PCI) with robot assistance is a non-surgical approach for implanting a stent that reduces the risk of orthopedic injury and operator fatigue. PCI (percutaneous coronary intervention) with robot assistance is a medical treatment for treating obstructive coronary artery disease and opening up blocked or restricted blood arteries. Compared to traditional percutaneous coronary intervention (PCI), robot assisted PCI has a higher success rate and accuracy.
Data Bridge Market Research analyses that the robot assisted Percutaneous Coronary Intervention (PCI) market is expected to undergo a CAGR of 11.7% during the forecast period of 2023 to 2030. “Robotic systems” dominates the product type segment of the Middle East and Africa robot assisted percutaneous coronary intervention (PCI) market owing to the rise in the incidence of cardiac diseases among the population. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Middle East and Africa Robot Assisted Percutaneous Coronary Intervention (PCI) Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015-2021)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
By Product Type (Robotic Systems, Instruments, and Accessories), End User (Hospitals, Cath Labs, and Others)-
|
|
Countries Covered
|
South Africa, Saudi Arabia, UAE, Rest of Middle East and Africa
|
|
Market Players Covered
|
|
|
Market Opportunities
|
|
Market Definition
Robotic technology is used to carry out minimally invasive operations to treat coronary artery disease. This technique is known as robot-assisted percutaneous coronary intervention (PCI). PCI, sometimes referred to as coronary angioplasty or balloon angioplasty, is a treatment performed to open constrictions or obstructions in the coronary arteries, which carry blood to the heart muscle.
Middle East and Africa Robot Assisted Percutaneous Coronary Intervention (PCI) Market Dynamics
Drivers
- Increasing geriatric population
Cardiovascular disease, including coronary artery disease, is more common in the elderly and frequently requires procedures like PCI. Robot-assisted PCI is a beneficial alternative for this population since it can provide better precision and results than conventional PCI approaches.
- Rising technological advancements
Robot-assisted percutaneous coronary intervention (PCI) has been developed and improved significantly as a result of technological developments. These developments are meant to improve the technology's potential, effectiveness, and security. A continuing technological development is a reduction in the size of robotic PCI instruments. More precise navigation via intricate coronary arteries is made possible by smaller, more flexible catheters and guidewires. Additionally, as a result of the miniaturisation, individuals with a wider spectrum of medical conditions can now benefit from robot-assisted PCI.
- Increasing demand of robotic assisted surgery
Robotic-assisted operations, such as percutaneous coronary intervention (PCI), have become more and more popular recently. The development and acceptance of robotic technology in the field of surgery is one of the elements driving this increased need. Comparing robotic-assisted surgery to conventional surgical methods, better patient outcomes may be possible. Robotic systems' improved precision, stability, and control can result in superior surgical results, including fewer problems, shorter hospital stays, and quicker recovery times. More and more patients are looking for surgical treatments that provide better results and faster recovery.
Opportunities
- Growing demand for minimally invasive approaches
Robot-assisted PCI is a minimally invasive technique, necessitating fewer incisions than standard open-heart operations. Numerous advantages may result from this, including decreased pain, shortened hospital stays, quicker healing times, and a lower risk of problems following major surgery.
- Rising integration of imaging and augmented reality
Robot-assisted PCI can be combined with cutting-edge imaging methods like augmented reality and three-dimensional imaging. When these technologies are combined, the procedure can be visualised and guided in real-time, improving the interventions' accuracy and precision. There is a lot of potential for procedure outcomes and patient safety to be further improved by combining robotic systems with cutting-edge imaging modalities.
- Increasing demand of telemedicine
Remote interventions are now possible in places with little access to specialised medical care thanks to improvements in robotics and telemedicine. Robot-assisted PCI operations can be remotely guided and carried out by skilled interventional cardiologists, giving patients in underserved areas access to high-quality cardiovascular treatment. In addition to enhancing patient outcomes, this can lessen healthcare inequities and increase the scope of expert interventions.
Restraint
- Strict regulations
PCI, with robot assistance may have difficulties with regulations and payment. Standards and recommendations for the use of robotic systems in interventional cardiology need to be developed by regulatory authorities. In order to guarantee proper compensation for healthcare practitioners and encourage wider access to the technology, reimbursement regulations should also take into account the higher expenses related to robot-assisted treatments.
- High cost and accessibility
Purchasing and maintaining robotic devices can be expensive. For healthcare organisations, the original investment and recurring costs for upkeep, training, and system improvements, may present financial difficulties. Because of its expensive price, the technique may not be widely available, particularly in areas with few resources or small healthcare budgets.
Challenge
- Limited clinical evidence
Robot-assisted PCI has the potential to produce better results, but there isn't enough clinical data to confirm it's better than regular PCI yet. It is necessary to conduct extensive clinical trials and long-term follow-up research to determine the long-term safety, effectiveness, and financial viability of this technology. A lack of strong clinical evidence can make it difficult to persuade regulatory agencies and healthcare professionals of the benefits of robot-assisted PCI.
- Lack of skilled professionals
A robotic system operator needs specialized knowledge and skills. To become skilled in using the robotic system for PCI procedures, interventional cardiologists and their colleagues must go through extensive training programs. The training procedure may need devoted time and money because the learning curve can be severe. To meet this problem, it is crucial to guarantee access to sufficient training programs and develop standardized certification procedures.
This Middle East and Africa robot assisted percutaneous coronary intervention (PCI) market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses of opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the robot assisted Percutaneous Coronary Intervention (PCI) market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Middle East and Africa Robot Assisted Percutaneous Coronary Intervention (PCI) Market Scope
Middle East and Africa robot assisted percutaneous coronary intervention (PCI) market is segmented on the basis of product type and end-user. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
Product type
- Robotic systems
- Instruments
- Accessories
End User
- Hospitals
- Cath labs
- Others
Middle East and Africa Robot Assisted Percutaneous Coronary Intervention (PCI) Market Regional Analysis/Insights
Middle East and Africa robot assisted percutaneous coronary intervention (PCI) market is analyzed and market size insights and trends are provided by country, product type and end-user as referenced above.
The countries covered in the Middle East and Africa robot assisted percutaneous coronary intervention (PCI) market report are South Africa, Saudi Arabia, UAE, Rest of Middle East and Africa.
South Africa is expected to dominate the robot assisted percutaneous coronary intervention (PCI) market due to increasing prevalence of cardiovascular diseases and growing demand of robotic assisted surgeries.
U.A.E is expected to be the fastest-growing country due to the increased demand of robotic assisted suregery.
The country section of the Middle East and Africa robot assisted percutaneous coronary intervention (PCI) market report also provides individual market impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of Middle East and Africa brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
Middle East and Africa robot assisted percutaneous coronary intervention (PCI) market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for Middle East and Africa robot assisted percutaneous coronary intervention (PCI) market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on Middle East and Africa robot assisted percutaneous coronary intervention (PCI) market. The data is available for historic period 2015 to 2020.
Competitive Landscape and Middle East and Africa ROBOT ASSISTED PERCUTANEOUS CORONARY INTERVENTION (PCI) Market Share Analysis
Middle East and Africa robot assisted percutaneous coronary intervention (PCI) market competitive landscape provides details by a competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, Middle East and Africa presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, and application dominance. The above data points provided are only related to the companies’ focus related to Middle East and Africa robot assisted percutaneous coronary intervention (PCI) market.
Some of the major players operating in the Middle East and Africa robot assisted percutaneous coronary intervention (PCI) market are:
- Corindus, Inc. (U.S.)
- Robocath, Inc. (France)
- Meerecompany Inc. (South Korea)
- Stryker (U.S.)
- Medtronic (Ireland)
- Intuitive Surgical (U.S.)
- Zimmer Biomet (U.S.)
- Smith+Nephew (U.S.)
- Asensus Surgical US, Inc (U.S.)
- Medrobotics Corporation (U.S.)
- THINK Surgical, Inc (U.S.)
- Auris Health, Inc (U.S.)
- CMR Surgical Ltd (U.K.)
- Medtech Life Pvt. Ltd (India)
SKU-